Report cover image

Global Special Medical Purpose Infant Formula Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Jul 07, 2025
Length 106 Pages
SKU # APRC20340174

Description

Summary

According to APO Research, The global Special Medical Purpose Infant Formula market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Special Medical Purpose Infant Formula is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Special Medical Purpose Infant Formula is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Special Medical Purpose Infant Formula is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Special Medical Purpose Infant Formula include Abbott, Nestle, Danone, Bayer, Real Food Blends, ProNourish, MeadJohnson, Kate Farms and Glanbia Nutritionals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Special Medical Purpose Infant Formula, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Special Medical Purpose Infant Formula.

The Special Medical Purpose Infant Formula market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Special Medical Purpose Infant Formula market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Special Medical Purpose Infant Formula Segment by Company

Abbott
Nestle
Danone
Bayer
Real Food Blends
ProNourish
MeadJohnson
Kate Farms
Glanbia Nutritionals
Fresenius Kabi
Cambrooke Therapeutics
Ajinomoto
Special Medical Purpose Infant Formula Segment by Type

Amino Acid Metabolism Disorders
Breast Milk Nutritional Supplements
Extended Hydrolysis of Milk Protein
Lactose-free or Low-lactose
Premature/low Birth Weight Infants
Other
Special Medical Purpose Infant Formula Segment by Application

Pediatrics
Neonatal Intensive Care
Other
Special Medical Purpose Infant Formula Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Special Medical Purpose Infant Formula market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Special Medical Purpose Infant Formula and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Special Medical Purpose Infant Formula.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Special Medical Purpose Infant Formula manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Special Medical Purpose Infant Formula in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

106 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Special Medical Purpose Infant Formula Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Special Medical Purpose Infant Formula Sales Estimates and Forecasts (2020-2031)
1.3 Special Medical Purpose Infant Formula Market by Type
1.3.1 Amino Acid Metabolism Disorders
1.3.2 Breast Milk Nutritional Supplements
1.3.3 Extended Hydrolysis of Milk Protein
1.3.4 Lactose-free or Low-lactose
1.3.5 Premature/low Birth Weight Infants
1.3.6 Other
1.4 Global Special Medical Purpose Infant Formula Market Size by Type
1.4.1 Global Special Medical Purpose Infant Formula Market Size Overview by Type (2020-2031)
1.4.2 Global Special Medical Purpose Infant Formula Historic Market Size Review by Type (2020-2025)
1.4.3 Global Special Medical Purpose Infant Formula Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Special Medical Purpose Infant Formula Sales Breakdown by Type (2020-2025)
1.5.2 Europe Special Medical Purpose Infant Formula Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Special Medical Purpose Infant Formula Sales Breakdown by Type (2020-2025)
1.5.4 South America Special Medical Purpose Infant Formula Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Special Medical Purpose Infant Formula Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Special Medical Purpose Infant Formula Industry Trends
2.2 Special Medical Purpose Infant Formula Industry Drivers
2.3 Special Medical Purpose Infant Formula Industry Opportunities and Challenges
2.4 Special Medical Purpose Infant Formula Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Special Medical Purpose Infant Formula Revenue (2020-2025)
3.2 Global Top Players by Special Medical Purpose Infant Formula Sales (2020-2025)
3.3 Global Top Players by Special Medical Purpose Infant Formula Price (2020-2025)
3.4 Global Special Medical Purpose Infant Formula Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Special Medical Purpose Infant Formula Major Company Production Sites & Headquarters
3.6 Global Special Medical Purpose Infant Formula Company, Product Type & Application
3.7 Global Special Medical Purpose Infant Formula Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Special Medical Purpose Infant Formula Market CR5 and HHI
3.8.2 Global Top 5 and 10 Special Medical Purpose Infant Formula Players Market Share by Revenue in 2024
3.8.3 2023 Special Medical Purpose Infant Formula Tier 1, Tier 2, and Tier 3
4 Special Medical Purpose Infant Formula Regional Status and Outlook
4.1 Global Special Medical Purpose Infant Formula Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Special Medical Purpose Infant Formula Historic Market Size by Region
4.2.1 Global Special Medical Purpose Infant Formula Sales in Volume by Region (2020-2025)
4.2.2 Global Special Medical Purpose Infant Formula Sales in Value by Region (2020-2025)
4.2.3 Global Special Medical Purpose Infant Formula Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Special Medical Purpose Infant Formula Forecasted Market Size by Region
4.3.1 Global Special Medical Purpose Infant Formula Sales in Volume by Region (2026-2031)
4.3.2 Global Special Medical Purpose Infant Formula Sales in Value by Region (2026-2031)
4.3.3 Global Special Medical Purpose Infant Formula Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Special Medical Purpose Infant Formula by Application
5.1 Special Medical Purpose Infant Formula Market by Application
5.1.1 Pediatrics
5.1.2 Neonatal Intensive Care
5.1.3 Other
5.2 Global Special Medical Purpose Infant Formula Market Size by Application
5.2.1 Global Special Medical Purpose Infant Formula Market Size Overview by Application (2020-2031)
5.2.2 Global Special Medical Purpose Infant Formula Historic Market Size Review by Application (2020-2025)
5.2.3 Global Special Medical Purpose Infant Formula Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Special Medical Purpose Infant Formula Sales Breakdown by Application (2020-2025)
5.3.2 Europe Special Medical Purpose Infant Formula Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Special Medical Purpose Infant Formula Sales Breakdown by Application (2020-2025)
5.3.4 South America Special Medical Purpose Infant Formula Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Special Medical Purpose Infant Formula Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Abbott
6.1.1 Abbott Comapny Information
6.1.2 Abbott Business Overview
6.1.3 Abbott Special Medical Purpose Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Abbott Special Medical Purpose Infant Formula Product Portfolio
6.1.5 Abbott Recent Developments
6.2 Nestle
6.2.1 Nestle Comapny Information
6.2.2 Nestle Business Overview
6.2.3 Nestle Special Medical Purpose Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Nestle Special Medical Purpose Infant Formula Product Portfolio
6.2.5 Nestle Recent Developments
6.3 Danone
6.3.1 Danone Comapny Information
6.3.2 Danone Business Overview
6.3.3 Danone Special Medical Purpose Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Danone Special Medical Purpose Infant Formula Product Portfolio
6.3.5 Danone Recent Developments
6.4 Bayer
6.4.1 Bayer Comapny Information
6.4.2 Bayer Business Overview
6.4.3 Bayer Special Medical Purpose Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Bayer Special Medical Purpose Infant Formula Product Portfolio
6.4.5 Bayer Recent Developments
6.5 Real Food Blends
6.5.1 Real Food Blends Comapny Information
6.5.2 Real Food Blends Business Overview
6.5.3 Real Food Blends Special Medical Purpose Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Real Food Blends Special Medical Purpose Infant Formula Product Portfolio
6.5.5 Real Food Blends Recent Developments
6.6 ProNourish
6.6.1 ProNourish Comapny Information
6.6.2 ProNourish Business Overview
6.6.3 ProNourish Special Medical Purpose Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.6.4 ProNourish Special Medical Purpose Infant Formula Product Portfolio
6.6.5 ProNourish Recent Developments
6.7 MeadJohnson
6.7.1 MeadJohnson Comapny Information
6.7.2 MeadJohnson Business Overview
6.7.3 MeadJohnson Special Medical Purpose Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.7.4 MeadJohnson Special Medical Purpose Infant Formula Product Portfolio
6.7.5 MeadJohnson Recent Developments
6.8 Kate Farms
6.8.1 Kate Farms Comapny Information
6.8.2 Kate Farms Business Overview
6.8.3 Kate Farms Special Medical Purpose Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Kate Farms Special Medical Purpose Infant Formula Product Portfolio
6.8.5 Kate Farms Recent Developments
6.9 Glanbia Nutritionals
6.9.1 Glanbia Nutritionals Comapny Information
6.9.2 Glanbia Nutritionals Business Overview
6.9.3 Glanbia Nutritionals Special Medical Purpose Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Glanbia Nutritionals Special Medical Purpose Infant Formula Product Portfolio
6.9.5 Glanbia Nutritionals Recent Developments
6.10 Fresenius Kabi
6.10.1 Fresenius Kabi Comapny Information
6.10.2 Fresenius Kabi Business Overview
6.10.3 Fresenius Kabi Special Medical Purpose Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Fresenius Kabi Special Medical Purpose Infant Formula Product Portfolio
6.10.5 Fresenius Kabi Recent Developments
6.11 Cambrooke Therapeutics
6.11.1 Cambrooke Therapeutics Comapny Information
6.11.2 Cambrooke Therapeutics Business Overview
6.11.3 Cambrooke Therapeutics Special Medical Purpose Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Cambrooke Therapeutics Special Medical Purpose Infant Formula Product Portfolio
6.11.5 Cambrooke Therapeutics Recent Developments
6.12 Ajinomoto
6.12.1 Ajinomoto Comapny Information
6.12.2 Ajinomoto Business Overview
6.12.3 Ajinomoto Special Medical Purpose Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Ajinomoto Special Medical Purpose Infant Formula Product Portfolio
6.12.5 Ajinomoto Recent Developments
7 North America by Country
7.1 North America Special Medical Purpose Infant Formula Sales by Country
7.1.1 North America Special Medical Purpose Infant Formula Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Special Medical Purpose Infant Formula Sales by Country (2020-2025)
7.1.3 North America Special Medical Purpose Infant Formula Sales Forecast by Country (2026-2031)
7.2 North America Special Medical Purpose Infant Formula Market Size by Country
7.2.1 North America Special Medical Purpose Infant Formula Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Special Medical Purpose Infant Formula Market Size by Country (2020-2025)
7.2.3 North America Special Medical Purpose Infant Formula Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Special Medical Purpose Infant Formula Sales by Country
8.1.1 Europe Special Medical Purpose Infant Formula Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Special Medical Purpose Infant Formula Sales by Country (2020-2025)
8.1.3 Europe Special Medical Purpose Infant Formula Sales Forecast by Country (2026-2031)
8.2 Europe Special Medical Purpose Infant Formula Market Size by Country
8.2.1 Europe Special Medical Purpose Infant Formula Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Special Medical Purpose Infant Formula Market Size by Country (2020-2025)
8.2.3 Europe Special Medical Purpose Infant Formula Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Special Medical Purpose Infant Formula Sales by Country
9.1.1 Asia-Pacific Special Medical Purpose Infant Formula Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Special Medical Purpose Infant Formula Sales by Country (2020-2025)
9.1.3 Asia-Pacific Special Medical Purpose Infant Formula Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Special Medical Purpose Infant Formula Market Size by Country
9.2.1 Asia-Pacific Special Medical Purpose Infant Formula Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Special Medical Purpose Infant Formula Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Special Medical Purpose Infant Formula Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Special Medical Purpose Infant Formula Sales by Country
10.1.1 South America Special Medical Purpose Infant Formula Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Special Medical Purpose Infant Formula Sales by Country (2020-2025)
10.1.3 South America Special Medical Purpose Infant Formula Sales Forecast by Country (2026-2031)
10.2 South America Special Medical Purpose Infant Formula Market Size by Country
10.2.1 South America Special Medical Purpose Infant Formula Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Special Medical Purpose Infant Formula Market Size by Country (2020-2025)
10.2.3 South America Special Medical Purpose Infant Formula Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Special Medical Purpose Infant Formula Sales by Country
11.1.1 Middle East and Africa Special Medical Purpose Infant Formula Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Special Medical Purpose Infant Formula Sales by Country (2020-2025)
11.1.3 Middle East and Africa Special Medical Purpose Infant Formula Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Special Medical Purpose Infant Formula Market Size by Country
11.2.1 Middle East and Africa Special Medical Purpose Infant Formula Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Special Medical Purpose Infant Formula Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Special Medical Purpose Infant Formula Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Special Medical Purpose Infant Formula Value Chain Analysis
12.1.1 Special Medical Purpose Infant Formula Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Special Medical Purpose Infant Formula Production Mode & Process
12.2 Special Medical Purpose Infant Formula Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Special Medical Purpose Infant Formula Distributors
12.2.3 Special Medical Purpose Infant Formula Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.